294 M. Hansson et al. / Developmental Biology 330 (2009) 286–304dur<strong>in</strong>g <strong>the</strong> 5 day activ<strong>in</strong> treatment. To monitor <strong>the</strong> effectiveness <strong>of</strong>Dkk1 treatment <strong>in</strong> reduc<strong>in</strong>g canonical Wnt signal<strong>in</strong>g we firstgenerated an <strong>ES</strong> cell l<strong>in</strong>e stably transfected with a SuperTOP-Ceruleanreporter (SuTOP-CFP) and established its ability to report Wntsignal<strong>in</strong>g <strong>in</strong> E10.5 chimeric embryos after <strong>in</strong>jection <strong>in</strong>to E3.5blastocysts and implantation <strong>in</strong>to pseudo-pregnant females. Asshown <strong>in</strong> Fig. S5A, native Cerulean fluorescence can be observed <strong>in</strong>several sites known to harbor active Wnt signal<strong>in</strong>g at this stage,<strong>in</strong>clud<strong>in</strong>g <strong>the</strong> peripheral aspects <strong>of</strong> <strong>the</strong> otic vesicles (Maretto et al.,2003). When SuTOP-CFP <strong>cells</strong> were cultured <strong>in</strong> activ<strong>in</strong> we found thatCFP + colonies developed at day 3 even <strong>in</strong> <strong>the</strong> absence <strong>of</strong> exogenousWnt addition and that additional treatment with Dkk1 reduced orabolished reporter activity depend<strong>in</strong>g on <strong>the</strong> duration <strong>of</strong> treatment(Fig. S5B). Similarly, when SuTOP-CFP <strong>cells</strong> were assayed at day 5, wefound that Dkk1 treatment at days 3–4 or4–5 <strong>in</strong>hibited reporteractivity (Fig. S5C). Thus, treatment with Dkk1 for as little as 1 to 2 daysat <strong>the</strong> concentration used appeared quite effective <strong>in</strong> suppress<strong>in</strong>gSuTOP reporter activity.We <strong>the</strong>n analyzed <strong>the</strong> number <strong>of</strong> T-GFP + <strong>cells</strong> develop<strong>in</strong>g <strong>in</strong>response to activ<strong>in</strong> when Wnt signal<strong>in</strong>g was experimentally perturbed.T-GFP + cell numbers were augmented by Wnt3a with <strong>the</strong>largest effect reached when Wnt3a was added only at day 3.Treatment with Dkk1 on <strong>the</strong> o<strong>the</strong>r hand reduced <strong>the</strong> number <strong>of</strong> T-GFP + <strong>cells</strong> most effectively when <strong>in</strong>cluded <strong>in</strong> that last part <strong>of</strong> <strong>the</strong>three day period (Fig. 5A). Nei<strong>the</strong>r stimulat<strong>in</strong>g nor <strong>in</strong>hibit<strong>in</strong>g Wntsignal<strong>in</strong>g <strong>in</strong> Gsc Gfp/+ <strong>cells</strong>, by treatment with Wnt3a and Dkk1,respectively, resulted <strong>in</strong> a significant change <strong>in</strong> <strong>the</strong> number <strong>of</strong> activ<strong>in</strong><strong>in</strong>ducedGFP + <strong>cells</strong> irrespective <strong>of</strong> <strong>the</strong> treatment period (Fig. 5B).However, treatment <strong>of</strong> Sox17 Gfp/+ <strong>cells</strong> with Wnt3a prior toappearance <strong>of</strong> GFP + <strong>cells</strong> reduced <strong>the</strong> number <strong>of</strong> Sox17-GFP Hi <strong>cells</strong>,while later Wnt3a treatment had no effect. Conversely, treatment withDkk1 reduced <strong>the</strong> number <strong>of</strong> Sox17-GFP Hi <strong>cells</strong> only if present after <strong>the</strong>first appearance <strong>of</strong> <strong>the</strong>se (Fig. 5C).We next used siRNA mediated knock-down <strong>of</strong> β-caten<strong>in</strong> (encodedby Ctnnb1) to confirm that <strong>in</strong>hibition <strong>of</strong> canonical Wnt signal<strong>in</strong>g at <strong>the</strong>latter part <strong>of</strong> <strong>the</strong> 5 day activ<strong>in</strong> stimulation period could suppress <strong>the</strong>appearance <strong>of</strong> Sox17-GFP Hi <strong>cells</strong> and to fur<strong>the</strong>r test <strong>the</strong> Gsc Gfp/+ celll<strong>in</strong>e which appeared refractory to Wnt <strong>in</strong>hibition <strong>in</strong> previousexperiments. We transfected Gsc Gfp/+ and Sox17 Gfp/+ <strong>cells</strong> withcontrol and two different Ctnnb1 siRNAs at day 2 <strong>of</strong> <strong>differentiation</strong>and assayed β-caten<strong>in</strong> expression by western blott<strong>in</strong>g at days 3 and 5.In Gsc Gfp/+ <strong>cells</strong> we found a reduction <strong>of</strong> β-caten<strong>in</strong> expression at day 3which was normalized at day 5. siRNA treatment appeared moreeffective <strong>in</strong> Sox17 Gfp/+ <strong>cells</strong> with strong <strong>in</strong>hibition <strong>of</strong> β-caten<strong>in</strong>expression at day 3 which was only partly recovered by day 5(Fig. 6A). FACS analysis at day 5 showed a reduction <strong>in</strong> <strong>the</strong> number <strong>of</strong>Gsc-GFP + <strong>cells</strong> after β-caten<strong>in</strong> knock-down, although this onlyreached significance <strong>in</strong> Ctnnb1 siRNA2 treated samples (pb0.05,Fig. 6B). Fur<strong>the</strong>rmore, Q-RT-PCR analysis <strong>of</strong> Gsc Gfp/+ <strong>cells</strong> after β-caten<strong>in</strong> knock-down did not reveal significant changes <strong>in</strong> expression<strong>of</strong> Lhx1 and Chrd (Fig. S6).However, <strong>in</strong> agreement with <strong>the</strong> results obta<strong>in</strong>ed with Dkk1treatment, we found a prom<strong>in</strong>ent reduction <strong>in</strong> <strong>the</strong> number <strong>of</strong> Sox17-GFP Hi <strong>cells</strong> at day 5, <strong>in</strong> both siRNA1 and siRNA2 treated samples(pb0.05, Fig. 6B).Activ<strong>in</strong> dose-dependently <strong>in</strong>duces an anterior gene expression patternTo determ<strong>in</strong>e whe<strong>the</strong>r <strong>the</strong> DE formed <strong>in</strong> <strong>the</strong> presence <strong>of</strong> highconcentrations <strong>of</strong> activ<strong>in</strong> was anterior or posterior <strong>in</strong> character weanalyzed <strong>the</strong> expression <strong>of</strong> a number <strong>of</strong> markers display<strong>in</strong>g differentialexpression depend<strong>in</strong>g on <strong>the</strong> anterior–posterior position <strong>of</strong> <strong>the</strong> <strong>cells</strong>.RT-PCR analyses at day 5 showed that activ<strong>in</strong>, regardless <strong>of</strong>concentration, could <strong>in</strong>duce expression <strong>of</strong> genes associated withanterior cell fates, <strong>in</strong>clud<strong>in</strong>g Lefty1, Hex, (Mart<strong>in</strong>ez-Barbera et al.,2000) and Otx2, (Rh<strong>in</strong>n et al., 1998). However, robust expression <strong>of</strong>Fig. 6. Inhibition <strong>of</strong> canonical Wnt signal<strong>in</strong>g <strong>in</strong>hibits activ<strong>in</strong>-<strong>in</strong>duced Sox17-GFP Hi def<strong>in</strong>itive endoderm formation, but has little effect on Gsc expression. (A) Western blot analysis <strong>of</strong>β-caten<strong>in</strong> expression after siRNA mediated knock-down. Two different siRNAs target<strong>in</strong>g β-caten<strong>in</strong> (siRNA1 and siRNA2) or a scrambled control siRNA were <strong>in</strong>troduced to Gsc Gfp/+and Sox17 Gfp/+ cell l<strong>in</strong>es on day 2 and β-caten<strong>in</strong> levels assayed at day 3 and 5. An anti-β-act<strong>in</strong> western blot served as load<strong>in</strong>g control. (B) siRNA treated Gsc Gfp/+ and Sox17 Gfp/+ <strong>cells</strong>were analyzed for GFP expression by flow cytometry after 5 days <strong>of</strong> serum-free culture supplemented with 0, 3 or 100 ng/ml activ<strong>in</strong>. The mean % GFP + <strong>cells</strong> ±standard deviation <strong>of</strong>three <strong>in</strong>dependent experiments is presented. Untransfected and mock transfected controls are also shown.
M. Hansson et al. / Developmental Biology 330 (2009) 286–304295Cer1 as well as repression <strong>of</strong> <strong>the</strong> posterior marker Cdx2 was only seen<strong>in</strong> <strong>the</strong> presence <strong>of</strong> <strong>the</strong> high activ<strong>in</strong> concentration (Fig. 7A). In contrast,Cdx2 (Beck et al., 1995) was expressed <strong>in</strong> samples treated with 10 ng/ml BMP4 or 100 ng/ml Wnt3a, as well as <strong>cells</strong> treated with <strong>the</strong> lowdose <strong>of</strong> activ<strong>in</strong> (Fig. 7A). We next isolated Gsc-GFP + and Gsc-GFP −<strong>cells</strong> as well as Sox17-GFP Hi , Sox17-GFP Lo and Sox17-GFP − <strong>cells</strong> fromactiv<strong>in</strong>-stimulated cultures at day 5 by FACS and prepared RNA forgene expression analysis. Message for Otx2 and Cer1 was detected <strong>in</strong>both Gsc-GFP + and Gsc-GFP − fractions, but with an enrichment <strong>in</strong> <strong>the</strong>GFP + fraction (Fig. 7B). Cer1 was also enriched <strong>in</strong> Sox17-GFP Hi <strong>cells</strong>compared to Sox17-GFP − and Sox17-GFP Lo <strong>cells</strong> (Fig. 7B). Fur<strong>the</strong>rmore,when analyz<strong>in</strong>g <strong>the</strong> expression <strong>of</strong> <strong>the</strong> respective DE and VEmarkers, Pyy and Tdh (Hou et al., 2007; Sherwood et al., 2007) weonly found Pyy <strong>in</strong> <strong>the</strong> Sox17-GFP Hi <strong>cells</strong> while Tdh was found <strong>in</strong> <strong>the</strong>Sox17-GFP − and, to a lesser degree, Sox17-GFP Lo populations (Fig. 7B).However, it should be noted that FACS sorted populations are probablynot completely pure. For example, <strong>the</strong> Sox17 Hi and Sox17 Lo populationsare likely display<strong>in</strong>g “cross-contam<strong>in</strong>ation” to some extent.F<strong>in</strong>ally, as Lhx1 is expressed <strong>in</strong> <strong>the</strong> anterior part <strong>of</strong> <strong>the</strong> PS <strong>in</strong> <strong>the</strong> latestreakembryo and expected to co-localize with Gsc (Shawlot andBehr<strong>in</strong>ger, 1995; Tada et al., 2005) we performed GFP-Lhx1 doubleimmun<strong>of</strong>luorescent sta<strong>in</strong><strong>in</strong>gs on Gsc Gfp/+ <strong>cells</strong> after 5 days <strong>of</strong><strong>differentiation</strong>. As expected, we found Gsc-GFP + Lhx1 + doublepositive <strong>cells</strong> <strong>in</strong> activ<strong>in</strong>-treated cultures and <strong>the</strong> formation <strong>of</strong> <strong>the</strong>se<strong>cells</strong> was <strong>in</strong>hibited by <strong>the</strong> addition <strong>of</strong> BMP4 but not Wnt3a (Fig. 7C).<strong>FGF</strong> receptor signal<strong>in</strong>g is required for mesendoderm and endoderm<strong>differentiation</strong>If <strong>FGF</strong> signal<strong>in</strong>g is compromised dur<strong>in</strong>g early development as <strong>in</strong><strong>FGF</strong>8, <strong>FGF</strong>R1, or UDP-glucose dehydrogenase mutants, <strong>the</strong> embryos'arrest at gastrulation and no embryonic mesoderm- or endodermderivedtissues develop (Ciruna et al., 1997; Deng et al., 1994; Garcia-Garcia and Anderson, 2003; Sun et al., 1999; Yamaguchi et al., 1994).The phenotype is associated with a failure <strong>of</strong> migration and it isunclear to what degree <strong>FGF</strong> signal<strong>in</strong>g regulates allocation <strong>of</strong>mesodermal and endodermal fates. However, studies <strong>in</strong> zebrafish<strong>in</strong>dicate that <strong>FGF</strong> signal<strong>in</strong>g promotes mesodermal development at <strong>the</strong>expense <strong>of</strong> endodermal development (Mathieu et al., 2004; Mizoguchiet al., 2006; Poula<strong>in</strong> et al., 2006). We first exam<strong>in</strong>ed <strong>the</strong>Fig. 7. Activ<strong>in</strong>, BMP and Wnt signal<strong>in</strong>g <strong>in</strong>fluence anterior–posterior pattern<strong>in</strong>g dur<strong>in</strong>g <strong>differentiation</strong> <strong>of</strong> <strong>ES</strong> <strong>cells</strong>. <strong>ES</strong> <strong>cells</strong> were grown for 5 days <strong>in</strong> serum-free medium supplementedwith <strong>in</strong>dicated growth factors. (A) The expression <strong>of</strong> Lefty1, Hex, Otx2, Cer1 and Cdx2 was analyzed <strong>in</strong> T Gfp/+ <strong>cells</strong> by RT-PCR. The expression <strong>of</strong> TATA b<strong>in</strong>d<strong>in</strong>g prote<strong>in</strong> (Tbp) was usedas <strong>in</strong>ternal standard. (B) <strong>ES</strong> <strong>cells</strong> were cultured with 100 ng/ml activ<strong>in</strong> and FACS sorted based on native GFP fluorescence after 5 days <strong>of</strong> culture. The expression <strong>of</strong> Otx2 and Cer1 wasanalyzed <strong>in</strong> <strong>the</strong> GFP + and GFP − fraction <strong>of</strong> Gsc Gfp/+ <strong>cells</strong>, and Otx2, Cer1, Pyy and Tdh expression was analyzed<strong>in</strong> <strong>the</strong> GFP Hi , GFP Lo and GFP − fraction <strong>in</strong> Sox17 Gfp/+ <strong>cells</strong>. Glucose-6-phosphate dehydrogenase (G6pd) was used as <strong>in</strong>ternal standard. (C) The expression <strong>of</strong> Lhx1 and GFP was exam<strong>in</strong>ed <strong>in</strong> Gsc Gfp/+ <strong>cells</strong> by immun<strong>of</strong>luorescence after 5 days <strong>in</strong> <strong>the</strong>presence <strong>of</strong> <strong>the</strong> <strong>in</strong>dicated factors.
- Page 1: PhD thesisCand.scient. Janny Marie
- Page 5: ResuméSukkersyge er en sygdom der
- Page 9: Table of contents1
- Page 12 and 13: ICMinner cell massIdInhibitor of di
- Page 14 and 15: cell mass regenerates probably thro
- Page 16 and 17: Figure 1-1: Early embryo developmen
- Page 18 and 19: Figure 1-3: Regional expression of
- Page 20 and 21: The pluripotent stateThe pluripoten
- Page 25 and 26: There are four membrane-bound FGFRs
- Page 27: 2. AimsThe aim of this study was to
- Page 30 and 31: Developmental Biology 330 (2009) 28
- Page 32 and 33: 288 M. Hansson et al. / Development
- Page 34 and 35: 290 M. Hansson et al. / Development
- Page 36 and 37: 292 M. Hansson et al. / Development
- Page 40 and 41: 296 M. Hansson et al. / Development
- Page 42 and 43: 298 M. Hansson et al. / Development
- Page 44 and 45: 300 M. Hansson et al. / Development
- Page 46 and 47: 302 M. Hansson et al. / Development
- Page 48 and 49: 304 M. Hansson et al. / Development
- Page 50 and 51: Figure S2Figure S2: A subpopulation
- Page 52 and 53: Figure S4Figure S4: Expression of T
- Page 54 and 55: Figure S6Figure S6: qRT-PCR analyse
- Page 56 and 57: epithelium; Cdx2, expressed posteri
- Page 58 and 59: Figure 4-4: A high FGF4-concentrati
- Page 60 and 61: Figure 4-6: A 3-step protocol does
- Page 63 and 64: 5. Paper IIFGFR(IIIc)-activation in
- Page 65 and 66: AbstractProgress in embryonic stem
- Page 67 and 68: variants in their Ig-like domain II
- Page 69 and 70: Cell count and proliferation assayC
- Page 71 and 72: influence on the numbers of Sox17-G
- Page 73 and 74: undifferentiated cells, we found th
- Page 75 and 76: FGF4, 5, FGF8b and FGFR1, are expre
- Page 77 and 78: with EdU-stain (blue sample); and w
- Page 79 and 80: Olsen, S.K., J.Y. Li, C. Bromleigh,
- Page 81 and 82: FiguresFigure 1: Screen for FGFR-is
- Page 83 and 84: Figure 3: Activation of FGFRb or FG
- Page 87 and 88: Opposite, Figure 6: In the absence
- Page 89 and 90:
6. General discussionEndoderm diffe
- Page 91 and 92:
Overall, the multitude of FGF-signa
- Page 93 and 94:
transplantation is the spread of an
- Page 96:
AcknowledgementsThe work presented
- Page 99 and 100:
Chambers, I., D. Colby, M. Robertso
- Page 101 and 102:
Hawkins, V.J. Wroblewski, D.S. Li,
- Page 103 and 104:
Nishikawa, S.I., S. Nishikawa, M. H
- Page 105 and 106:
Tanimizu, N., H. Saito, K. Mostov,